Carta Healthcare secures $18.25 million in Series B1 funding led by UPMC Enterprises to enhance AI-powered clinical data abstraction and analytics.
Carta Healthcare secures $18.25 million in Series B1 funding led by UPMC Enterprises to enhance AI-powered clinical data abstraction and analytics.
05/07/25, 1:22 PM
Location
san franciscoMoney raised
$18.3 million
Industry
medical
artificial intelligence
biotechnology
health care
Investors
Mass General Brigham Ventures, Cu Healthcare Innovation Fund, Paramark Ventures, Storm Ventures, Frist Cressey Ventures, Memorial Hermann Health System, Tampa General Hospital Ventures, Rex Health Ventures, Memorial Care Innovation Fund, Upmc Enterprises
Carta Healthcare has announced it raised $18.25 million in Series B1 financing to boost its growth. The investment aims to meet the rising demand for AI-driven data solutions in health systems. UPMC Enterprises led the round, with participation from multiple strategic investors. This funding will support the expansion of Carta Healthcare's innovative clinical data services.
Company Info
Location
san francisco, california, united states
Additional Info
At Carta Healthcare, we believe high-quality data is essential to improving healthcare. Current methods to abstract data for clinical registries are labor-intensive, time-consuming, and costly. By combining artificial intelligence (AI) technology with skilled expert abstractors, Carta Healthcare helps you abstract data faster, more efficiently, at a lower cost, while delivering the highest quality data.